Literature DB >> 12900774

A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.

M Eyrich1, C Leiler, P Lang, K Schilbach, M Schumm, P Bader, J Greil, T Klingebiel, R Handgretinger, D Niethammer, P G Schlegel.   

Abstract

Positively selected CD34(+) hematopoietic stem cells from unrelated donors (UD-HSCT) have been successfully transplanted, but little is known about immune reconstitution in this setting. Here we report a prospective comparison of immune reconstitution in recipients of UD-HSCT and of unmanipulated bone marrow from matched sibling donors (MSD-BMT). T-cell reconstitution occurred more than 100 days later in the UD-HSCT than in the MSD-BMT group. The first T cells after UD-HSCT were almost exclusively CD45RO(+) HLA-DR(+), whereas early-emerging T cells after MSD-BMT more frequently expressed CD62L, CD28, and CD25. In both groups, numbers of CD45RA(+) naive T cells increased after 180 days. After UD-HSCT, the T-cell-receptor (TCR)-repertoire was severely skewed and showed significantly reduced diversity during the first year, but only minor abnormalities were seen after MSD-BMT. TCR-diversity increased simultaneously with the number of naive T cells. In both groups, we observed transient expansions of gammadelta T cells. B cells were reconstituted more rapidly in UD-HSCT than in MSD-BMT recipients, whereas the rapidity of NK-cell reconstitution was similar in the two groups. In summary, T-cell reconstitution was slower after UD-HSCT than after MSD-BMT because of the delayed recovery of early memory-type T cells with reduced TCR-diversity, whereas naive T-, NK-, and B cells were reconstituted similarly in the two groups.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900774     DOI: 10.1038/sj.bmt.1704158

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  15 in total

1.  CCL25 increases thymopoiesis after androgen withdrawal.

Authors:  Kirsten M Williams; Philip J Lucas; Catherine V Bare; Jiun Wang; Yu-Waye Chu; Ezekiel Tayler; Veena Kapoor; Ronald E Gress
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

Review 2.  Evaluation of TCR repertoire diversity in patients after hematopoietic stem cell transplantation.

Authors:  Yangqiu Li; Ling Xu
Journal:  Stem Cell Investig       Date:  2015-09-28

3.  Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques.

Authors:  Ruth Seggewiss; Karin Loré; F Javier Guenaga; Stefania Pittaluga; Joseph Mattapallil; Catherine K Chow; Richard A Koup; Kevin Camphausen; Martha C Nason; Martin Meier-Schellersheim; Robert E Donahue; Bruce R Blazar; Cynthia E Dunbar; Daniel C Douek
Journal:  Blood       Date:  2007-03-20       Impact factor: 22.113

Review 4.  Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes.

Authors:  M Bemark; J Holmqvist; J Abrahamsson; K Mellgren
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

5.  The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation.

Authors:  Roberta Fedele; Massimo Martino; Cristina Garreffa; Giuseppe Messina; Giuseppe Console; Domenica Princi; Antonella Dattola; Tiziana Moscato; Elisabetta Massara; Elisa Spiniello; Giuseppe Irrera; Pasquale Iacopino
Journal:  Blood Transfus       Date:  2012-01-24       Impact factor: 3.443

Review 6.  Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.

Authors:  Kirsten M Williams; Ronald E Gress
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

7.  TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia.

Authors:  M Maschan; L Shelikhova; M Ilushina; E Kurnikova; E Boyakova; D Balashov; M Persiantseva; Y Skvortsova; A Laberko; Y Muzalevskii; A Kazachenok; S Glushkova; V Bobrynina; V Kalinina; Y Olshanskaya; D Baidildina; G Novichkova; A Maschan
Journal:  Bone Marrow Transplant       Date:  2016-01-25       Impact factor: 5.483

8.  Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood.

Authors:  Benjamin R Oshrine; Yimei Li; David T Teachey; Jennifer Heimall; David M Barrett; Nancy Bunin
Journal:  Biol Blood Marrow Transplant       Date:  2013-08-11       Impact factor: 5.742

Review 9.  The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation.

Authors:  Ioannis Politikos; Vassiliki A Boussiotis
Journal:  Blood       Date:  2014-10-06       Impact factor: 22.113

10.  A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation.

Authors:  Li Li; Han Chen; David Marin; Yuanxin Xi; Qi Miao; Jiangxing Lv; Pinaki Prosad Banerjee; Hila Shaim; May Daher; Rafet Basar; Nobuhiko Imahashi; Juan Jimenez; Bingqian Hu; Rohtesh S Mehta; Lucila Nassif Kerbauy; Mecit Kaplan; Mayela Mendt; Gonca Ozcan; Elif Gokdemir; Mayra Hernandez Sanabria; Ye Li; Ken Chen; Jing Wang; Luis Muniz-Feliciano; Wei-Li Zhao; Richard E Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood Adv       Date:  2019-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.